Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Neal Shahidi"'
Publikováno v:
VideoGIE, Vol 9, Iss 5, Pp 221-223 (2024)
Externí odkaz:
https://doaj.org/article/1a673add054548b5ace4bae0b4249132
Autor:
Sunil Gupta, Rajiv Kurup, Neal Shahidi, Sergei Vosko, Owen McKay, Simmi Zahid, Anthony Whitfield, Eric Y. Lee, Stephen John Williams, Nicholas Graeme Burgess, Michael J. Bourke
Publikováno v:
Endoscopy International Open, Vol 12, Iss 01, Pp E1-E10 (2024)
Externí odkaz:
https://doaj.org/article/81b5320f4e5c41338417fed9244fd6be
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 13 (2020)
Advances in minimally invasive tissue resection techniques now allow for the majority of early colorectal neoplasia to be managed endoscopically. To optimize their respective risk–benefit profiles, and, therefore, appropriately select between endos
Externí odkaz:
https://doaj.org/article/5a8446f177744d4297f1aebf56f3fa1f
Publikováno v:
Endoscopy International Open, Vol 05, Iss 04, Pp E239-E243 (2017)
Background/Study aim The American Society for Gastrointestinal Endoscopy (ASGE) recommends that trainees complete 150 endoscopic ultrasound (EUS) procedures before assessing competency. However, this recommendation is largely based on limited evidenc
Externí odkaz:
https://doaj.org/article/444928d136574b3680540ad19e9a0723
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 9 (2016)
Vedolizumab, an α4β7-integrin antagonist, is the first gut-selective monoclonal antibody that has been approved for the treatment of moderate-to-severe ulcerative colitis and Crohn’s disease in many countries in the world. However, questions stil
Externí odkaz:
https://doaj.org/article/e8dd700ec32441ddac41d7157aa04ebc
Autor:
Robert A. Mitchell, Constantin Shuster, Neal Shahidi, Cherry Galorport, Mari L. DeMarco, Gregory Rosenfeld, Robert A. Enns, Brian Bressler
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2016 (2016)
Background. Infliximab (IFX) therapeutic drug monitoring (TDM) allows for objective decision making in patients with inflammatory bowel disease (IBD) and loss of response. Questions remain about whether IFX TDM improves outcomes. Methods. Patients wi
Externí odkaz:
https://doaj.org/article/2477da58c20b4a5aa42e2e44c343b02e
Autor:
Neal Shahidi, Laura Gentile, Lovedeep Gondara, Jeremy Hamm, Colleen E. McGahan, Robert Enns, Jennifer Telford
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2016 (2016)
Background and Aims. The Canadian Partnership Against Cancer (CPAC) recommends a fecal immunochemical test- (FIT-) positive predictive value (PPV) for all adenomas of ≥50%. We sought to assess FIT performance among average-risk participants of the
Externí odkaz:
https://doaj.org/article/069522baafbf4a378a5be907a85f0be7
Publikováno v:
Yamada's Atlas of Gastroenterology. :775-781
Publikováno v:
Yamada's Atlas of Gastroenterology. :782-787
Publikováno v:
Successful Training in Gastrointestinal Endoscopy. :284-302